Documents reveal new details about Purdue’s marketing of OxyContin

Newly disclosed documents outline how aggressively Purdue Pharma sought to promote its prescription opioid painkiller OxyContin, with a member of the family owning the company telling an audience to create “a blizzard of prescriptions that will bury the competition.”

Read More